RAC 2.20% $1.78 race oncology ltd

From the strategic update in March 2021.Personally, I'm very...

  1. 1,234 Posts.
    lightbulb Created with Sketch. 12305
    https://hotcopper.com.au/data/attachments/3130/3130854-2478ddfb322ba02ab313883bc0ef6b6d.jpg
    From the strategic update in March 2021.

    Personally, I'm very interested to see if Bisantrene inhibits FTO in non-cancerous cells and how that effects the downstream expression of genes and the impact that has on cellular function, because there have been a couple non-cancerous diseases linked to overexpression of FTO. I don't know how much 'low-cost' is, but I believe the cost to reward ratio is worth taking a look at.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.